This Week in Earnings: Surprises, Slumps, and Standouts 📊

Last week was awesome! 

We just heard from over a hundred S&P 500 components and learned about their recent performance, their management's thoughts, and much more.

There were some sweet earnings reactions. 

And some pretty terrible ones, too...

Here's what we talked about last week:

• Monday:
  • Verisign $VRSN resolved a .com bubble base on the heels of its earnings report.
  • T-Mobile US $TMUS had its worst earnings reaction ever after reporting a double beat.
• Tuesday:
  • Domino's Pizza $DPZ rallied after reporting mixed results. It's carving out a sweet base.
  • Roper Technologies $ROP got crushed again for reporting a double beat. They've been punished for 6 of their last 7 reports.
• Wednesday:
  • S&P Global $SPGI reported a double beat and had its 2nd consecutive positive earnings reaction.
  • Teradyne $TER got crushed again for reporting a double beat. They've been punished for 8 of their last 9 reports. The stock now looks poised to resolve a massive top.
• Thursday:
  • Visa $V had a sweet reaction after reporting a double beat. The stock printed a bullish engulfing candlestick and reclaimed the VWAP anchored to the all-time high.
  • Caterpillar $CAT was rewarded for reporting a double miss. The stock is reclaiming former support and failing a massive top.
• Friday:
  • Microsoft $MSFT had its best earnings reaction since 2015 after reporting a double beat. The stock added over $200B to its market capitalization in a single session.
  • Eli Lilly $LLY had its worst earnings reaction ever after reporting a double beat. The stock is priced to perfection, and this report wasn't perfect.

Here's what we're watching next week:

On Monday, we'll hear from the AI leader, Palantir $PLTR.

Later in the week, we'll hear from Uber $UBER, Novo Nordisk $NVO, Coinbase $COIN, and much more.

There will be a lot to unpack here at The Beat Report.

We're looking forward to the Hims & Hers Health $HIMS earnings report.

Here's why:

Hims & Hers Health has been one of the best-performing stocks this cycle. It has rallied nearly 3,000%!

Last week, the company inked a deal with Novo Nordisk $NVO, and the stock ripped on the news.

The bulls followed through on the momentum and reclaimed the VWAP anchored to the all-time high.

We think HIMS is poised for more upside, and we think Monday's earnings report will add fuel to the current rally.

Thank you for reading.

- The Beat Report Team 

PS: Kenny’s 10–15% off sale for his Live Room, watchlist, and custom VWAP script is over. But if you're serious about trading with Kenny in real time, call Mary at 323-421-7910 or email mary@stockmarketmedia.com to see if you still qualify.

If you find our content valuable, we would greatly appreciate it if you could share it with your friends, family, and colleagues. Your help in spreading the word is invaluable in supporting our work. Thank you to all of you who share!